Moximed
PrivateLast Round
Series D
Aug 13, 2024
Total Funding Raised
$219M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Moximed is a medical device company that develops unicompartmental load absorber implants designed to enhance the treatment of osteoarthritis by reducing joint pain and potentially delaying the need for more invasive surgeries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Moximed Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Moximed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 13, 2024 | ||||
| Debt | Aug 16, 2022 | ||||
| Debt | Jul 14, 2022 | ||||
| Series C | Mar 15, 2017 | ||||
| Series B | May 7, 2015 | ||||
VC Round | Jun 30, 2011 |
Moximed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Runway Growth Capital | Debt |
| Frazier Healthcare Partners | VC Round |
| Vertex Ventures HC | Series D |
| New Enterprise Associates (NEA) | Series D, Series B, VC Round, Debt, Series C |
| Cormorant Asset Management | Series D |
| Future Fund | Series D, Debt, Series C |
| Advent Life Sciences | Series D, Series C, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
MISHA Knee System received FDA clearance for market.
- Feb 10, 2026
Launched the MISHA Knee System, an implantable shock absorber for knee osteoarthritis.
Moximed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Moximed's valuation, stock price, and market status.